Please tell
us what content you're looking for so that we can improve
our Web site. Email webmaster >
About CTI
Corporate Overview
• Business Strategy
• People & Facilities
• Collaborations
• Technologies
• Financial History
• Mission & Values
• Community Involvement
Calendar
Site Glossary
Cancer Resources
Products
Clinical Pipeline
• XYOTAX™ (CT-2103)
• Pixantrone
• CT-2106
• Clinical Trials
Preclinical/Discovery
• Novel Platinum Complexes
• HIF-1 Inhibitors
• Analyst Coverage
• Investor Kit
• Corporate Profile
News - Press Releases
Events - Webcasts
Stock
Investor Updates
• Stock
Chart
• Historical
Price Lookup
• Investment
Calculator
• Ownership Summary
Financial
Information
• SEC Filings
• Annual Reports
• Financial
Details
Corporate
Governance
 Board
of Directors
Executive
Management
FAQ & Info
Request
• Information
Request Form
• Fact Sheet
• Transfer Agent
E-Mail Alerts
MediaOnline Press Kits
• XYOTAX™
• Pixantrone
Press Releases & News Alerts
Quick Facts
CTI Logos
Biographies
CareerWorking at CTI
Job Postings
Apply
Compensation & Benefits
Living in Seattle
Contacting CTI
Terms of Use
Privacy Policy
Posted June 13, 2007
Copyright © 2004-2007 Cell Therapeutics, Inc., Seattle,
WA, USA. All rights reserved. "Making cancer more treatable" is a
registered mark of CTI.
|
